Lyell Immunopharma, Inc. (LYEL) reported Q3 Revenue

Lyell Immunopharma, Inc. (NASDAQ: LYEL) reported Q3 Revenue for the quarter came in at $34 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Lyell Immunopharma, Inc. (LYEL) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• M&T Bank Corp. (MTB) Declares $1.50 Quarterly Dividend; 2.4% Yield
• Offerpad to move stock listing from NYSE to Nasdaq